Skip to content

Fees in Respect of Drugs and Medical Devices Order

SOR/2019-124

In forceCurrent to September 30, 2026 HistoryRegistered on May 8, 2019Made under: Food and Drugs Act

Follow

Part 1 — General

Section 3

Marginal note:Non-application

  •  (1) This Order does not apply in respect of

    • (a) publicly funded health care institutions;

    • (b) branches or agencies of the Government of Canada or of the government of a province; or

    • (c) drugs that are the subject of an extraordinary use new drug submission filed under section C.08.002.01 of the Food and Drug Regulations or of an abbreviated extraordinary use new drug submission filed under section C.08.002.1 of those Regulations.

  • Marginal note:Definition of publicly funded health care institution

    (2) For the purposes of subsection (1), publicly funded health care institution means an institution that is funded by the Government of Canada or the government of a province and that is

    • (a) licensed, approved or designated by a province in accordance with the laws of the province to provide care or treatment to persons or animals suffering from any form of disease or illness; or

    • (b) owned or operated by the Government of Canada or the government of a province and that provides health services.

Version in force since April 1, 2020

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.